Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH
-
Narrated by:
-
By:
About this listen
In this episode of Trends from the Trenches, host Stan Gloss speaks with Howard Jacob, vice president of genomics research at AbbVie. They discuss Jacob’s beginnings at AbbVie, data siloing and “my data vs. our data” issues, and the role of funding in plan execution and leadership support. Jacob also delves into the origins of the AbbVie R&D Convergence Hub (ARCH—winner of a 2023 Bio-IT World Innovative Practices Award), how they secured a sizable investment for its development, leveraging ARCH for rare diseases, and the strategy behind disseminating info that was generated by ARCH.
Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.